Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents

Journal of Reproductive Immunology

Volumn 96, Issue 1-2, 2012, Pages 84-89

  Royse, Kathryn E ^a   Kempf, Mirjam Colette ^a   McGwin, Gerald ^a   Wilson, Craig M ^a   Tang, Jianming ^b   Shrestha, Sadeep ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Bacterial vaginosis; HIV 1; Toll like receptors

Indexed keywords

HISTIDINE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TYROSINE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL IMMUNITY; CD4 LYMPHOCYTE COUNT; CHLAMYDIASIS; CONCURRENT INFECTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GONORRHEA; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOGENETICS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VAGINAL LAVAGE; VAGINITIS;

ADOLESCENT; AFRICAN AMERICANS; CHLAMYDIA INFECTIONS; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GONORRHEA; HIV INFECTIONS; HIV-1; HUMANS; MALE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; VAGINOSIS, BACTERIAL;

EID: 84872369994     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.08.002     Document Type: Article

References (41)

1. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., Lowry S.F. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 2002, 186:1522-1525.
2. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 1983, 74:14-22.
3. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
4. Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008, 22:1493-1501.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of ld and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Brotman R.M. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J. Clin. Invest. 2011, 121:4610-4617.
7. Cauci S., Driussi S., De Santo D., Penacchioni P., Iannicelli T., Lanzafame P., De Seta F., Quadrifoglio F., De Aloysio D., Guaschino S. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J. Clin. Microbiol. 2002, 40:2147-2152.
8. Chen K.H., Zeng L., Gu W., Zhou J., Du D.Y., Jiang J.X. Polymorphisms in the toll-like receptor 9 gene associated with sepsis and multiple organ dysfunction after major blunt trauma. Br. J. Surg. 2011, 98:1252-1259.
9. Cohen C.R., Lingappa J.R., Baeten J.M., Ngayo M.O., Spiegel C.A., Hong T., Donnell D., Celum C., Kapiga S., Delany S., Bukusi E.A. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among african couples. PLoS Med. 2012, 9:e1001251.
10. Coleman J.S., Hitti J., Bukusi E.A., Mwachari C., Muliro A., Nguti R., Gausman R., Jensen S., Patton D., Lockhart D., Coombs R., Cohen C.R. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007, 21:755-759.
11. Culhane J.F., Nyirjesy P., Mccollum K., Goldenberg R.L., Gelber S.E., Cauci S. Variation in vaginal immune parameters and microbial hydrolytic enzymes in bacterial vaginosis positive pregnant women with and without mobiluncus species. Am. J. Obstet. Gynecol. 2006, 195:516-521.
12. Eschenbach D.A. History and review of bacterial vaginosis. Am. J. Obstet. Gynecol. 1993, 169:441-445.
13. Forney L.J., Foster J.A., Ledger W. The vaginal flora of healthy women is not always dominated by Lactobacillus species. J. Infect. Dis. 2006, 194:1468-1469. author reply 1469-70.
14. Genc M.R., Vardhana S., Delaney M.L., Onderdonk A., Tuomala R., Norwitz E., Witkin S.S. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 116:152-156.
15. Greenblatt R.M., Bacchetti P., Barkan S., Augenbraun M., Silver S., Delapenha R., Garcia P., Mathur U., Miotti P., Burns D. Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the women's interagency HIV study (WIHS). Sex. Transm. Dis. 1999, 26:143-151.
16. Hajishengallis G., Lambris J.D. Microbial manipulation of receptor crosstalk in innate immunity. Nat. Rev. Immunol. 2011, 11:187-200.
17. Hillier S.L., Nugent R.P., Eschenbach D.A., Krohn M.A., Gibbs R.S., Martin D.H., Cotch M.F., Edelman R., Pastorek J.G., Rao A.V., et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N. Engl. J. Med. 1995, 333:1737-1742.
18. Hummelen R., Fernandes A.D., Macklaim J.M., Dickson R.J., Changalucha J., Gloor G.B., Reid G. Deep sequencing of the vaginal microbiota of women with HIV. PLoS ONE 2010, 5:e12078.
19. Jamieson D.J., Duerr A., Klein R.S., Paramsothy P., Brown W., Cu-Uvin S., Rompalo A., Sobel J. Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet. Gynecol. 2001, 98:656-663.
20. Koumans E.H., Sternberg M., Bruce C., Mcquillan G., Kendrick J., Sutton M., Markowitz L.E. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 2007, 34:864-869.
21. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 2002, 162:1028-1032.
22. Lorenz E., Patel D.D., Hartung T., Schwartz D.A. Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of bacteroides fragilis lipopolysaccharide. Infect. Immun. 2002, 70:4892-4896.
23. Ma B., Forney L.J., Ravel J. Vaginal microbiome: rethinking health and disease. Annu. Rev. Microbiol. 2012, 10.1146/annurev-micro-092611-150157.
24. Mitchell C.M., Balkus J., Agnew K.J., Cohn S., Luque A., Lawler R., Coombs R.W., Hitti J.E. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res. Hum. Retroviruses 2008, 24:667-671.
25. Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991, 29:297-301.
26. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S., Mcculle S.L., Karlebach S., Gorle R., Russell J., Tacket C.O., Brotman R.M., Davis C.C., Ault K., Peralta L., Forney L.J. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4680-4687.
27. Rogers A.S., Futterman D.K., Moscicki A.B., Wilson C.M., Ellenberg J., Vermund S.H. The REACH project of the adolescent medicine HIV/AIDS research network: design, methods, and selected characteristics of participants. J. Adolesc. Health 1998, 22:300-311.
28. Schroder N.W., Schumann R.R. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
29. Schwebke J.R. Role of vaginal flora as a barrier to HIV acquisition. Curr. Infect. Dis. Rep. 2001, 3:152-155.
30. Schwebke J.R., Hillier S.L., Sobel J.D., Mcgregor J.A., Sweet R.L. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet. Gynecol. 1996, 88:573-576.
31. Sha B.E., Zariffard M.R., Wang Q.J., Chen H.Y., Bremer J., Cohen M.H., Spear G.T. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J. Infect. Dis. 2005, 191:25-32.
32. Spear G.T., St John E., Zariffard M.R. Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res. Ther. 2007, 4:25.
33. St John E., Mares D., Spear G.T. Bacterial vaginosis and host immunity. Curr. HIV/AIDS Rep. 2007, 4:22-28.
34. Taha T.E., Gray R.H., Kumwenda N.I., Hoover D.R., Mtimavalye L.A., Liomba G.N., Chiphangwi J.D., Dallabetta G.A., Miotti P.G. HIV infection and disturbances of vaginal flora during pregnancy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999, 20:52-59.
35. Taha T.E., Kumwenda N.I., Kafulafula G., Makanani B., Nkhoma C., Chen S., Tsui A., Hoover D.R. Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial. PLoS Clin. Trials 2007, 2:e10.
36. Verstraelen H., Verhelst R., Nuytinck L., Roelens K., De Meester E., De Vos D., Van Thielen M., Rossau R., Delva W., De Backer E., Vaneechoutte M., Temmerman M. Gene polymorphisms of toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae. J. Reprod. Immunol. 2009, 79:163-173.
37. Wang C.C., Mcclelland R.S., Reilly M., Overbaugh J., Emery S.R., Mandaliya K., Chohan B., Ndinya-Achola J., Bwayo J., Kreiss J.K. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J. Infect. Dis. 2001, 183:1017-1022.
38. Wilson C.M., Houser J., Partlow C., Rudy B.J., Futterman D.C., Friedman L.B. The REACH (reaching for excellence in adolescent care and health) project: study design, methods, and population profile. J. Adolesc. Health 2001, 29:8-18.
39. Witkin S.S., Linhares I.M., Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract. Res. Clin. Obstet. Gynaecol. 2007, 21:347-354.
40. Witkin S.S., Linhares I.M., Giraldo P., Ledger W.J. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin. Infect. Dis. 2007, 44:554-557.
41. Workowski K.A., Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm. Rep. 2010, 59:1-110.